Skip to content
PDAB – which stands for Prescription Drug Affordability Board – is an acronym that you might hear more lately, as more and more states […]
PDABs bring the problem of drug price controls to the state level Read More »
With Pakistan’s monumental floods and the crop-withering heatwave in China this year as examples of what to expect, a new UN report last week
UN report warns humanity ‘going in wrong direction’ on climate change Read More »
A purple tomato from Norfolk Plant Sciences, with higher antioxidants thanks to the addition of two genes, was assessed positively by the USDA’s Animal
USDA greenlights purple tomato with enhanced antioxidants Read More »
Regulatory improvements and support for biotechnology research were among the actions that the U.S. Department of Health and Human Services (HHS) announced Wednesday as
HHS to boost biotech with regulatory improvements, research support Read More »
Top U.S. health officials reported a decline in the growth of new monkeypox cases and outlined the federal response to the outbreak, during a
Officials tell Senate hearing growth rate of monkeypox cases is slowing Read More »
U.S. federal health officials announced on Tuesday “a new phase” in the government’s COVID-19 response. The next phase, according to President Joe Biden’s statement
Americans can expect annual COVID-19 boosters, says White House Read More »
The gut bacteria that regulate the body’s biological clock could help people “battle sleep disorders, combat jet lag, fight off foodborne illness and can
Gut bacteria can fight sleep disorders, improve chemo, says UVA study Read More »
The U.S. Food and Drug Administration (FDA) approved last week Sanofi Genzyme’s Xenpozyme “for intravenous infusion in pediatric and adult patients with Acid Sphingomyelinase
FDA approves Sanofi’s Xenpozyme, the first treatment for ASMD Read More »
Preventable risk factors, including smoking and drinking alcohol, are the main cause of approximately 50% of cancer deaths, says a new study. A large-scale
Preventable risk factors cause 50% of cancer deaths globally Read More »
It’s an exciting time for research into microbiome therapeutics. This can be seen in the explosion of new clinical studies in the field, which,
A gut check on microbiome therapeutics development Read More »
